Paper33596994
BRG1 knockdown inhibits proliferation through multiple cellular pathways in prostate cancer.
Giles KA and 9 others. Clin Epigenetics, 2021. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. BRG1 knockdown inhibits proliferation through multiple cellular pathways in prostate cancer. Papers, record 33596994. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33596994
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- BRG1 knockdown inhibits proliferation through multiple cellular pathways in prostate cancer.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Proliferation | Major topic |
| Chromatin Assembly and Disassembly | Major topic |
| DNA Helicases | Major topic |
| Nuclear Proteins | Major topic |
| Prostatic Neoplasms | Major topic |
| Transcription Factors | Major topic |
| Cell Cycle | |
| Cell Line, Tumor | |
| DNA Replication | |
| Down-Regulation | |
| Gene Expression | |
| Humans | |
| Male | |
| Promoter Regions, Genetic | |
| Transcription, Genetic |
Source PubMed
References101
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12775722 | Differential requirement of SWI/SNF for androgen receptor activity. | J Biol Chem | 2003 | https://conductscience.org/library/papers/12775722 | PubMed |
| 2 | 18487222 | Prohibitin and the SWI/SNF ATPase subunit BRG1 are required for effective androgen antagonist-mediated transcriptional repression of androgen receptor-regulated genes. | Carcinogenesis | 2008 | https://conductscience.org/library/papers/18487222 | PubMed |
| 3 | 29187165 | ImageJ2: ImageJ for the next generation of scientific image data. | BMC Bioinformatics | 2017 | https://conductscience.org/library/papers/29187165 | PubMed |
| 4 | 26336819 | FOXA1 regulates androgen receptor variant activity in models of castrate-resistant prostate cancer. | Oncotarget | 2015 | https://conductscience.org/library/papers/26336819 | PubMed |
| 5 | 28115623 | Sas3 and Ada2(Gcn5)-dependent histone H3 acetylation is required for transcription elongation at the de-repressed FLO1 gene. | Nucleic Acids Res | 2017 | https://conductscience.org/library/papers/28115623 | PubMed |
| 6 | 30496141 | Chromatin remodeling ATPase BRG1 and PTEN are synthetic lethal in prostate cancer. | J Clin Invest | 2019 | https://conductscience.org/library/papers/30496141 | PubMed |
| 7 | 18386774 | Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines. | Hum Mutat | 2008 | https://conductscience.org/library/papers/18386774 | PubMed |
| 8 | 24227677 | featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. | Bioinformatics | 2014 | https://conductscience.org/library/papers/24227677 | PubMed |
| 9 | 22659453 | Vav3-rac1 signaling regulates prostate cancer metastasis with elevated Vav3 expression correlating with prostate cancer progression and posttreatment recurrence. | Cancer Res | 2012 | https://conductscience.org/library/papers/22659453 | PubMed |
| 10 | 10778858 | Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. | Cell | 2000 | https://conductscience.org/library/papers/10778858 | PubMed |
| 11 | 21765461 | A novel nuclear role for the Vav3 nucleotide exchange factor in androgen receptor coactivation in prostate cancer. | Oncogene | 2012 | https://conductscience.org/library/papers/21765461 | PubMed |
| 12 | 27079975 | deepTools2: a next generation web server for deep-sequencing data analysis. | Nucleic Acids Res | 2016 | https://conductscience.org/library/papers/27079975 | PubMed |
| 13 | 27435934 | SMARCA4 regulates gene expression and higher-order chromatin structure in proliferating mammary epithelial cells. | Genome Res | 2016 | https://conductscience.org/library/papers/27435934 | PubMed |
| 14 | 23586463 | Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. | BMC Bioinformatics | 2013 | https://conductscience.org/library/papers/23586463 | PubMed |
| 15 | 17075831 | Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers. | Prostate | 2007 | https://conductscience.org/library/papers/17075831 | PubMed |
| 16 | 21969603 | Dynamic nucleosome-depleted regions at androgen receptor enhancers in the absence of ligand in prostate cancer cells. | Mol Cell Biol | 2011 | https://conductscience.org/library/papers/21969603 | PubMed |
| 17 | 24916973 | Reconfiguration of nucleosome-depleted regions at distal regulatory elements accompanies DNA methylation of enhancers and insulators in cancer. | Genome Res | 2014 | https://conductscience.org/library/papers/24916973 | PubMed |
| 18 | 28706277 | DNA binding drives the association of BRG1/hBRM bromodomains with nucleosomes. | Nat Commun | 2017 | https://conductscience.org/library/papers/28706277 | PubMed |
| 19 | 24445599 | Gene silencing associated with SWI/SNF complex loss during NSCLC development. | Mol Cancer Res | 2014 | https://conductscience.org/library/papers/24445599 | PubMed |
| 20 | 25425964 | The long non-coding RNA PCAT-1 promotes prostate cancer cell proliferation through cMyc. | Neoplasia | 2014 | https://conductscience.org/library/papers/25425964 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42840510 | SWI/SNF chromatin remodelers in prostate cancer progression. | Front Epigenet Epigenom | 2023 | https://conductscience.org/library/papers/42840510 | PubMed |
| 42236527 | Loss of Brg1 prevents the progression of pulmonary hypertension by inhibiting Nrf2 expression. | Sci Rep | 2026 | https://conductscience.org/library/papers/42236527 | PubMed |
| 42170760 | Interplay of the 3D genome and epigenome in androgen-driven prostate cancer. | Epigenomics | 2026 | https://conductscience.org/library/papers/42170760 | PubMed |
| 40302186 | SAE1 May Play a Pro-Carcinogenic Role in Pancreatic Adenocarcinoma: A Comprehensive Study Integrating Multiple Pieces of Evidence. | IET Syst Biol | 2025 | https://conductscience.org/library/papers/40302186 | PubMed |
| 40075035 | Construction of a prognostic risk model for clear cell renal cell carcinomas based on centrosome amplification-related genes. | Mol Genet Genomics | 2025 | https://conductscience.org/library/papers/40075035 | PubMed |
| 39905188 | Identification of selective SWI/SNF dependencies in enzalutamide-resistant prostate cancer. | Commun Biol | 2025 | https://conductscience.org/library/papers/39905188 | PubMed |
| 39187513 | BRG1 promotes progression of B-cell acute lymphoblastic leukemia by disrupting PPP2R1A transcription. | Cell Death Dis | 2024 | https://conductscience.org/library/papers/39187513 | PubMed |
| 38978225 | BRG1 promotes liver cancer cell proliferation and metastasis by enhancing mitochondrial function and ATP5A1 synthesis through TOMM40. | Cancer Biol Ther | 2024 | https://conductscience.org/library/papers/38978225 | PubMed |
| 38661008 | Non-canonical role for the BAF complex subunit DPF3 in mitosis and ciliogenesis. | J Cell Sci | 2024 | https://conductscience.org/library/papers/38661008 | PubMed |
| 38446332 | Impact of carbamazepine on SMARCA4 (BRG1) expression in colorectal cancer: modulation by KRAS mutation status. | Invest New Drugs | 2024 | https://conductscience.org/library/papers/38446332 | PubMed |
| 37433987 | The role of chromatin remodeler SMARCA4/BRG1 in brain cancers: a potential therapeutic target. | Oncogene | 2023 | https://conductscience.org/library/papers/37433987 | PubMed |
| 37025180 | The epigenetic function of androgen receptor in prostate cancer progression. | Front Cell Dev Biol | 2023 | https://conductscience.org/library/papers/37025180 | PubMed |
| 36769189 | BRG1: Promoter or Suppressor of Cancer? The Outcome of BRG1's Interaction with Specific Cellular Pathways. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36769189 | PubMed |
| 35233061 | OTUD6A promotes prostate tumorigenesis via deubiquitinating Brg1 and AR. | Commun Biol | 2022 | https://conductscience.org/library/papers/35233061 | PubMed |
| 35158828 | Alternative Splicing, Epigenetic Modifications and Cancer: A Dangerous Triangle, or a Hopeful One? | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35158828 | PubMed |
| 34900673 | Biological Adaptations of Tumor Cells to Radiation Therapy. | Front Oncol | 2021 | https://conductscience.org/library/papers/34900673 | PubMed |
| 34283056 | Chromatin and Epigenetic Dysregulation of Prostate Cancer Development, Progression, and Therapeutic Response. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34283056 | PubMed |
Genes38
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33596994
GET https://conductscience.org/api/papers/v1/33596994/references?page=2